Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

Value Health. 2022 Mar;25(3):382-384. doi: 10.1016/j.jval.2021.09.006. Epub 2021 Nov 2.

¹ Department of Pathology and Cell Biology, Columbia University, New York, NY, USA; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Columbia Stem Cell Initiative, Columbia University Medical Center, New York, NY, USA; Digestive and Liver Diseases Research Center, Columbia University, New York, NY, USA. Electronic address: pdd2109@columbia.edu.

No abstract available

Publication types